Ipamorelin Peptide Ipamorelin Peptide CJC 1295 Ipamorelin CJC-1295 is a long-acting growth hormone releasing hormone (GHRH) analogue that stimulates the pituitary gland to secrete more endogenous growth hormone. When combined with ipamorelin—a selective ghrelin receptor agonist—this duo creates a synergistic effect, often referred to as a "peptide stack." The combination is prized for its ability to enhance muscle protein synthesis, accelerate fat loss, and improve recovery without the excessive side-effects associated with direct growth hormone injections. Key features of CJC-1295 Ipamorelin include: Extended duration: Unlike short-acting peptides, CJC-1295 remains active in the bloodstream for up to 24 hours, allowing a single daily dose. Reduced hunger stimulation: Ipamorelin is designed to trigger growth hormone release with minimal appetite increase, making it more suitable for weight-loss regimens. Balanced hormonal profile: The pair promotes a natural rise in growth hormone while keeping insulin-like growth factor 1 (IGF-1) levels within healthy limits. Ipamorelin Peptide Oral Spray An oral spray formulation of ipamorelin offers an alternative to subcutaneous injections. While peptides are traditionally delivered via injection due to their protein nature, advances in delivery technology have produced sprays that can be absorbed through the mucosal lining of the mouth or nose. Benefits of the oral spray include: Convenience: No needles required; easy to incorporate into a daily routine. Rapid onset: The spray allows for quicker absorption compared with injection, though it may still require multiple doses per day to match the sustained release of injectable forms.